RxNorm Semantic Concepts Index - 590
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "590".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 59002 | Etazocine | Designated preferred name (PT) | NO | |
| RxCUI: 59002 | Etazocine | Full form of descriptor (FN) | NO | |
| RxCUI: 59038 | chitosan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59039 | Dibutoline | Designated preferred name (PT) | NO | |
| RxCUI: 59039 | Dibutoline | Full form of descriptor (FN) | NO | |
| RxCUI: 59053 | oxolamine citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 59053 | oxolamine citrate | Designated preferred name (PT) | NO | |
| RxCUI: 59053 | oxolamine citrate | Full form of descriptor (FN) | NO | |
| RxCUI: 59064 | piperidolate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59064 | piperidolate | Designated preferred name (PT) | NO | |
| RxCUI: 59064 | piperidolate | Full form of descriptor (FN) | NO | |
| RxCUI: 59065 | Protokylol | Designated preferred name (PT) | NO | |
| RxCUI: 59065 | Protokylol | Full form of descriptor (FN) | NO | |
| RxCUI: 590706 | Holo-transcobalamin II | Designated preferred name (PT) | NO | |
| RxCUI: 590706 | Holo-transcobalamin II | Full form of descriptor (FN) | NO | |
| RxCUI: 59078 | metaxalone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 59078 | metaxalone | Designated preferred name (PT) | YES | |
| RxCUI: 59078 | metaxalone | Full form of descriptor (FN) | YES | |
| RxCUI: 59078 | metaxalone | Designated preferred name (PT) | YES | |
| RxCUI: 59078 | metaxalone | Full form of descriptor (FN) | YES | |
| RxCUI: 59082 | myrtecaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59082 | myrtecaine | Designated preferred name (PT) | NO | |
| RxCUI: 59082 | myrtecaine | Full form of descriptor (FN) | NO | |
| RxCUI: 590821 | Active (C3b)nBb | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 590821 | Active (C3b)nBb | Designated preferred name (PT) | NO | |
| RxCUI: 590821 | Active (C3b)nBb | Full form of descriptor (FN) | NO | |
| RxCUI: 590821 | Active (C3b)nBb | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 59087 | Eucalyptus oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 59087 | Eucalyptus oil | Designated preferred name (PT) | YES | |
| RxCUI: 59087 | Eucalyptus oil | Full form of descriptor (FN) | YES | |
| RxCUI: 59087 | Eucalyptus oil | Full form of descriptor (FN) | YES | |
| RxCUI: 59094 | cyclopentamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 59094 | cyclopentamine | Designated preferred name (PT) | NO | |
| RxCUI: 59094 | cyclopentamine | Full form of descriptor (FN) | NO |